Cargando…
Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
BACKGROUND: Currently, no test can accurately predict the development of azotemia after treatment of hyperthyroidism. Serum cystatin C concentrations (sCysC) might be less influenced by changes in body muscle mass and so better indicate the presence of concurrent chronic kidney disease (CKD) in hype...
Autores principales: | Williams, T.L., Dillon, H., Elliott, J., Syme, H.M., Archer, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084826/ https://www.ncbi.nlm.nih.gov/pubmed/27155206 http://dx.doi.org/10.1111/jvim.13956 |
Ejemplares similares
-
Relationship between Plasma Fibroblast Growth Factor‐23 Concentration and Survival Time in Cats with Chronic Kidney Disease
por: Geddes, R.F., et al.
Publicado: (2015) -
Risk Factors for Development of Chronic Kidney Disease in Cats
por: Finch, N.C., et al.
Publicado: (2016) -
Breed, Coat Color, and Hair Length as Risk Factors for Hyperthyroidism in Cats
por: Crossley, V.J., et al.
Publicado: (2017) -
Serum Beta Hydroxybutyrate Concentrations in Cats with Chronic Kidney Disease, Hyperthyroidism, or Hepatic Lipidosis
por: Gorman, L., et al.
Publicado: (2016) -
Evaluation of Serum Symmetric Dimethylarginine Concentration as a Marker for Masked Chronic Kidney Disease in Cats With Hyperthyroidism
por: Peterson, M.E., et al.
Publicado: (2018)